The insulin-sensitizing drugs metformin and rosiglitazone increased the number of ovulatory cycles six- to eightfold and ameliorated hyperandrogenemia in nonobese women with polycystic ovary syndrome (PCOS) and normal indices of insulin sensitivity.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.